The global semen analysis market will increase at a CAGR of 8.9% from 2017 to 2022 to USD 355.6 million by 2022, driven by lifestyle change, growing disposable income in the developing countries, increasing animal health expenditure, growing animal population, and rising demand for animal derived food products, and increase in fertility tourism.
However, high cost of assisted reproductive technology and imposition of medical device excise tax in the U.S. are expected to hinder the growth of the market to some extent.
The global semen analysis market is mainly segmented by application (human, veterinary), product (analyzers, accessories and disposables, software, instruments and test kit), and geography (North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa).
The global semen analysis market is fragmented with the presence of many local and regional players. The leading companies have employed various strategies to expand their product and services offerings, global footprint, and augment their market share. The key strategy followed by most companies in the global semen analysis market was new product launches/ developments, during the period of 2014-2017, enabling companies to expand their product offerings and ensure a competitive edge in the global semen analysis market.
The key players in this market are
- Bioline Technologies
- ContraVac INC
- Dolo Animals Ltd.
- Hamilton Thorne
- LabIVF Asia PTE. LTD.
- MedSystems International LLC
- Medical Electronics System LTD.
- Microptic S.L.
- MotilityCount Aps
- Sperm Processor Pvt. Ltd.
Key Topics Covered:
2 Executive Summary
3 Market Insights
4 Global Semen Analysis Market, By Application
5 Global Semen Analysis Market, By Products
6 Semen Analysis Market, By Geography
7 Global Semen Analysis Market- Competitive Landscape
8 Company Profiles
For more information about this report visit http://www.researchandmarkets.com/research/sdjxx6/global_semen